The aim of this study was to determine 1-year symptomatic outcome and its predictors in patients with first-episode psychosis (FEP) treated at 3 different publicly funded sites.
T rajectories of outcome in psychotic disorders may be established relatively early following onset of psychosis. [1] [2] [3] [4] [5] During this so-called "critical period," interventions may have the greatest impact on outcome. 6, 7 This and an association between the DUP and outcome [8] [9] [10] have stimulated a burgeoning interest in recent years regarding treatment and outcome of FEP. 11, 12 Most recent studies have reported generally high rates of initial response to treatment and clinical remission. [13] [14] [15] There is evidence that this initial response is often related to several factors, including sex, [16] [17] [18] age of onset, 19 DUP, 8, 9, 12 and adherence to treatment. 15, 20 Some of the inconsistency reported in clinical outcome and its predictors may be related to variations in assessment and treatment protocols used by different centres, methods of sampling, and differences in social circumstances of populations from which samples are derived. Only a few studies have reported results based on epidemiologic samples where the centre had a clearly defined catchment area and there was no competing service available to the population. [13] [14] [15] 21 Whether patients with an FEP have similar outcomes in specialized EI services in different jurisdictions can only be assessed by comparing outcomes from various treatment centres that use similar protocols of assessment and treatment and where treatment is provided in identical health care systems. However, rarely do different studies use identical evaluation and (or) treatment protocols. So far, there have not been any reports comparing outcomes in FEP from centres sharing the same health care system and using the same evaluation protocols. The influence of location of programs (for example, larger urban, compared with small urban) or of demographic variables such as ethnoracial characteristics, education, and social class has also not been adequately examined. Although the Treatment and Intervention in Psychosis project was conducted in several centres in Norway and Denmark that shared a common treatment and evaluation protocol and similar health care systems, data relevant to any variation in outcome between centres have not been reported. 22 Exploring differences in outcomes between EI services operating in different settings may help us assess whether the encouraging results reported from EI services are generally applicable across settings. Such data may also draw attention to how local factors are likely to influence outcome and indicate the importance of addressing such factors in developing models of care.
Here we report 1-year outcome on FEP patients with little or no previous experience of treatment, who were treated in 3 different specialized, publicly funded treatment programs that used a common protocol for assessment procedures and similar treatment protocols. In this report, we confine ourselves to examining symptomatic improvement over a period of 1 year. We hypothesized that rate of clinical improvement would be relatively high (that is, the proportion of patients showing clinical improvement) for the entire sample. An examination of any differences in outcome between different centres was not based on a priori hypothesis, owing to the lack of any such evidence in previous studies.
Methods

Treatment Setting and Subject Recruitment
This multisite study was conducted in 4 academic centres, each with a service designed specifically for treatment of FEP. We chose not to include data from one site because the initial assessment at this centre was delayed and did not reflect the true pretreatment symptom status of most subjects. In the following paragraphs, we briefly describe each of the remaining 3 centres:
The FEPP at the Centre for Addiction and Mental Health, part of a large teaching hospital, is situated in a downtown area of a large metropolitan centre (Toronto) with no clearly defined catchment area for the treatment program. Most patients seeking treatment live within the city of Toronto (population 2.5 million). The FEPP comprises 3 distinct but interconnected services: an outpatient FEP clinic, a HIP dedicated to FEP patients, and an 18-bed inpatient Early Psychosis Unit. Patients were approached to participate in this study once they had been identified and assessed by 1 of these 3 teams. Care within the FEP clinic and the HIP team both involve being assigned a case manager (nurse, social worker, or occupational therapist) as well as a psychiatrist. Families receive support and education from the case manager and psychiatrist and, in more challenging cases, a dedicated family specialist. Efforts are made to facilitate return to work or school by the treatment team, in some cases in conjunction with a specialized community-based program. Patients are monitored closely and the staff-patient ratio is at a level considered optimal by staff. The Hamilton Psychotic Disorders Clinic provides assessment and treatment to a population of 200 000 in the western part of Hamilton, with no competing services. It comprises a small interdisciplinary team, including a psychiatrist, which has adopted a care coordinator model. A nurse care coordinator, a family educator, and an occupational therapist work together to provide the care traditionally offered by a case manager. 23 The care coordinator assesses the individual client's needs, coordinates service delivery, and monitors medication adherence, safety, and side effect profiles. The care coordinator also provides education about the illness, medication, and negative impact of substance abuse to promote recovery. The family educator offers family education and support, often chairing partnership meetings involving any member of the team, the patient, or the family, to review progress, provide psychoeducation, manage crises, and negotiate treatment plans involving all the above partners in care. Finally, the occupational therapist helps the client articulate short-and long-term goals for recovery. The occupational therapist encourages client involvement in community and psychosocial interventions and an increase in structured activities and promotes return to work or school.
The PEPP, London, Ontario, is a specialized service that provides assessment and treatment to all cases of nonaffective FEP within an urban catchment area of 409 000. The program provides prompt access (48 to 72 hours) to referrals from any source. There is no competing public or private facility for FEP in the catchment area. Although assessment and treatment are preferably offered in an outpatient community setting, the program includes direct access to a 10-bed unit dedicated to early psychosis treatment and serviced by the same psychiatrists who provide care in the outpatient community component of PEPP, assuring continuity of care. The treatment program in PEPP incorporates an assertive case management model modified to address the special needs of a younger, treatment-naive patient population and is staffed by 6 case managers (nursing or social work discipline), an occupational therapist, a clinical psychologist specializing in cognitive-behavioural therapy, and psychiatrists equivalent to 2.5 full-time positions. Case managers are expected to provide care to 12 new cases per year for a 2-year period. All patients are offered a structured family psychoeducation intervention; careful monitoring of their symptoms, medication adherence, and level of functioning through assertive case management; group interventions directed at improving their social-personal skills and self-efficacy; and cognitivebehavioural therapy for postpsychotic dysphoric and residual psychotic symptoms. The details of the interventions have been provided elsewhere. 24 Pharmacologic treatment at all centres included a flexible protocol of low-dosage novel antipsychotic medications (risperidone, olanzapine, or quetiapine) prescribed up to a maximum tolerated dosage within the range recommended in the manufacturer's guidelines. Clozapine was generally offered after an unsuccessful trial of at least 2 antipsychotic medications. Patients who had been initially started on treatment with a typical antipsychotic prior to referral and who were beginning to show a good response, with no side effects, were maintained on the same medication. Patients with difficulty in adherence to medication were offered depot typical antipsychotics. Adjunct medications such as antidepressants and mood stabilizers were prescribed as clinically indicated.
Study Inclusion-Exclusion Criteria
To be included, patients had to be seeking treatment for a first episode of nonaffective psychosis; to meet DSM-IV diagnostic criteria for a psychotic disorder within the schizophrenia spectrum (schizophrenia, schizophreniform or schizoaffective psychosis, delusional disorder, and psychosis not otherwise specified); to have not received previous antipsychotic therapy for more than 30 days; to be treated initially as voluntary inpatients or outpatients; to be between 16 and 50 years old; and to be willing and able to sign an informed consent to participate in the evaluation study.
Patients were excluded if they had a primary diagnosis of mood disorder, alcohol or other drug dependence, psychosis secondary to a major medical or neurologic disorder, epilepsy, or an IQ of less than 70. Patients who were initially admitted under an involuntary status were approached to participate in the study as soon as their status was changed to voluntary.
Assessments and Variable of Interest
Diagnosis was established with the Structured Clinical Interview for DSM-IV. 25 All patients were administered a shortened version of the CORS, a semistructured interview to establish age of onset of first-ever psychiatric symptoms, first psychotic symptoms, and duration of psychotic symptoms at a threshold level for the syndrome of psychosis prior to initiation of antipsychotic therapy and to determine pathways to care. 14, 15, 26 Initiation of antipsychotic therapy was defined as continuous use of antipsychotic treatment for a period of 30 days (or less if remission occurred earlier). Information on demographic characteristics was obtained as part of the CORS interview and included age, sex, marital and educational status, living arrangements, and ethnicity. DUP was calculated from the time of onset of psychotic symptoms to the time of initiation of continuous antipsychotic treatment, plus any periods of psychosis previously experienced and spontaneously remitted.
Symptom assessments were conducted with the PANSS 27 at baseline, 6 months, and 12 months. For this report, the key outcome variables were symptoms as assessed with the PANSS. This instrument yields a total score for overall psychopathology (total PANSS, 30 items) and has subscales that yield data on positive symptoms of psychosis (7 items), negative symptoms of psychosis (7 items), and overall general psychopathology (16 items) . Each item is scored on a 7-point severity scale, resulting in a range of possible scores from 30 to 210 for the total score, a possible range of 7 to 49 for the positive and negative symptoms subscales, and a possible range of 16 to 112 for the psychopathology score. The alpha coefficients of reliability reported for the PANSS scale scores are 0.73 for the Positive subscale, 0.83 for the Negative subscale, and 0.79 for the General Psychopathology subscale. 27 Raters at each centre were trained at the coordinating centre (London, Ontario) on all instruments. Interrater reliability was established at these training sessions. The intraclass correlations for PANSS total scores and subscale scores were established for 2 videotaped cases and varied between 0.86 and 0.91 among raters across all sites.
The original construction of the PANSS produced 3 factors: positive syndrome, negative syndrome, and general psychopathology. 27 Although, in later studies, more than 20 different factor structures with solutions ranging between 3 and 7 factors have been suggested, no distinct advantages have been demonstrated with larger numbers of factors. Therefore, we used the original structure of the 3 subscales in the present study to make our results more comparable with the previous literature.
Data Analysis
To test for the effects of time and centre on the main outcomes (PANSS scores: Total, Negative Symptoms, Positive Symptoms, and Psychopathology), we used mixed model ANOVA (SAS MIXED procedure, SAS version 9.1, SAS Institute Inc, Cary, NC). Time (baseline, 6-month assessment, and 12-month assessment) and centre (Hamilton, London, and Toronto) and interactions between centre and time were entered as fixed effects. The correlation of the repeated measures within each patient was modelled with the use of a random subject intercept and an unstructured covariance matrix. Subjects nested within centres were included as random effects to account for variation due to centres.
Sex and DUP were included as covariates. Additionally, we controlled for ethnicity, diagnosis of schizoaffective disorder, and education. Main effects and interactions were regarded as statistically significant when P was less than 0.05. The same analysis approach was used for all outcome variables (PANSS scores: Total, Negative Symptoms, Positive Symptoms, and General Psychopathology).
Results
A total of 223 patients were approached to participate at the 3 sites (Hamilton, 40; London, 66; and Toronto, 117). Of these, 174 patients accepted and signed an informed consent (Hamilton, 34; London, 56; Toronto, 84), while 49 patients refused to participate (6, 10, and 33, respectively, from the 3 sites). In addition, 38 patients (6, 1, and 22, respectively) who were admitted for treatment to the respective programs were not eligible for the study. The reasons for ineligibility were that they had either received previous treatment for more than 30 days (1, 0, and 22, respectively) or had an IQ of less than 70 (5, 1, and 0). There were 35 other patients who were eligible; however, they were not approached for the following reasons: too paranoid or hostile (4, 3, and 0), dropped out of treatment before they could be approached (2, 2, 0), language problems (0, 1, 0), episode too brief (1, 0, 0), and involuntary status (0, 0, 13).
Of those entered in the study, reliable data were available on 172 patients (34, 55, and 83, respectively for the 3 sites). Of these patients, 33 were lost to follow-up (4, 4, 25, respectively). The 3 centres were similar with respect to sex, age, and marital status. However, one centre (Toronto) differed with respect to ethnicity with less than one-half of the patients being of white ethnicity, compared with nearly three-fourths in the 2 other centres. Patients in one centre (London) had lower levels of education than those in the other 2 centres.
There was a significant difference in the diagnostic distribution between centres, with the differences accounted for primarily by a higher proportion of patients with diagnosis of schizo-affective disorder at one site (Hamilton). These sociodemographic and clinical characteristics are presented in Table 1 .
Symptom Change
The mean baseline PANSS scores were similar at the 3 centres, although patients in Hamilton had somewhat lower baseline scores than patients in London and Toronto.
Considering the differences between the 3 centres on education, ethnicity, and diagnosis, we controlled for these in our mixed model ANOVA. Total PANSS scores and PANSS subscale scores decreased over time in all centres (Tables 2 to  5 ). This improvement was evident at 6 months, with additional change in the subsequent 6 months. The mixed model revealed significant variation in treatment effects for different dimensions of outcome over time. Improvement was greatest for the Positive Symptoms subscales: mean scores decreased by more than 2 SDs from baseline to 6-month assessment. The improvement for the General Psychopathology subscale was somewhat lower (1.5 SDs decrease after 6 months), while the least improvement was found for the Negative Symptoms subscale (mean scores decreased by less than 1 SD from baseline to 6-month assessment). There were only small differences between 6-month and 12-month assessment. Although PANSS scores decreased in all centres, there was a significant centre´time interaction for the total score as well as for all 3 subscales. These interactions indicate that improvement was different across the 3 centres: Mean 6-month and 12-month assessment PANSS scores were higher in Toronto than in Hamilton and London on all measures.
The highest variability of the PANSS scores was found in London for all symptom measures except negative symptoms: SDs at 6-month and 12-month assessment were much higher than in Hamilton and Toronto, indicating a heterogeneous outcome at this site.
DUP was not associated with change in PANSS scores.
After 6 and 12 months, men and women had similar Positive Symptoms and Psychopathology scores; however, women had lower scores on the Total and Negative Symptom composites (significant sex effect in mixed model analysis).
Discussion
Our results confirmed a relatively high rate of improvement, especially on positive symptoms, following treatment of FEP in specialized treatment programs. The most significant results reported here include the influence of site of treatment on clinical outcome and the lack of association between symptom change and DUP. The differences in clinical outcome at different sites could not be explained by differences in such patient characteristics as age, sex, education, marital status, ethnicity, or diagnosis. While all 3 sites operated under the same publicly funded system of health care and criteria for inclusion in the study and evaluations were standardized across all sites, there may be other differences between centres that were not captured in this protocol. These may include subtle differences in the delivery of services, local system of referral to the program at each site, size and characteristics of the population covered by respective programs, and availability of other services in the respective jurisdictions.
The differences in outcome between centres may be related to differences in the extent to which subjects recruited for the study were representative of all cases of FEP in the population. In the 2 medium-sized communities (London and Hamilton, Ontario, with catchment area populations of around 400 000 and 200 000, respectively), there were no competing psychiatric services available to patients. However, in Toronto (with a population of 2.5 million within the city itself and a population of 5 million in the Greater Toronto Area), there are several competing services potentially available to patients, with no clearly defined catchment area for each of these services. This may have resulted in selective recruitment of subjects in the study at the Toronto site who possess other characteristics, not included in the study protocol, that portend both poor outcome and higher attrition rates.
Our data indicate that rate of initial refusal to participate and eventual attrition rates were higher in Toronto. More complicated cases may have been referred to a facility regarded as primarily providing tertiary care. In large metropolitan centres, there are likely to be a relatively high number of transient residents who present for treatment of an FEP. All sites, however, provided services to university students who are also likely to be relatively transient in their living arrangements. It is possible that specialized services for FEP may function better when organized around definite catchment area populations of modest sizes, such as the ones in London and Hamilton, even within large urban centres. Such organization may allow smaller and more manageable teams to provide services with greater fidelity to a model of a specialized EI service. The absence of an association between DUP and clinical outcome is not in agreement with what has been reported in systematic reviews recently published. 8, 9, 28 However, several reports have failed to find this association. 15, 29 Such variation in results may be related to the outcome variable selected (for example, level of symptoms at 1 year, compared with time to remission or change in symptoms over time), sample heterogeneity, or the extent to which subjects included are representative of all cases of FEP. We based our results on a uniform protocol for assessment of DUP and symptoms, recruitement of consecutive patients seeking treatment at each site, inclusion criterion of previous treatment of no more than 30 days, and controlling for differences between sites in the analysis. Samples from multiple sites may introduce additional heterogeneity that conceals the effect of DUP on symptom outcome. Such a relation between DUP and symptoms may be present in only a proportion of patients. This problem requires a more detailed and complex statistical approach, such as latent class analysis, which is provided in a separate report. 30 The relatively higher level of improvement of positive and general symptoms, compared with the low level of improvement in negative symptoms, confirms similar results reported previously in samples of FEP. The lack of substantial effect on negative symptoms is likely the result of lower efficacy of antipsychotic drugs for negative symptoms and the fact that, in a proportion of FE patients, negative symptoms may be closer to trait characteristics than transitory symptom states. This is likely to affect improvement in functional outcome, which will be reported separately.
To the best of our knowledge, this is the first multicentre study reporting the influence of treatment site on rates of clinical improvement in FEP treated at specialized treatment programs within a publicly funded mental health system. Our data do not allow us to examine all the possibly complex reasons underlying such differences beyond a number of patient characteristics, which were controlled for in our data. Our data are also limited to initial response to treatment over a 1-year period; a longer-term follow-up may be more informative about the influence of the nature of and the manner in which treatment is provided and the influence of local social and geographic factors on outcome. The strengths of this report include the uniformity of the assessment protocol, similarity of treatment programs, lack of previous treatment for subjects included, and a high degree of precision in estimating complex variables such as DUP. Our findings may suggest that implementation of EI service will require modifications, depending on the jurisdiction in which they are established, especially in large urban centres, if one is to achieve high rates of improvement in all jurisdictions. Such modifications may involve smaller and more easily administered service units serving defined populations of modest sizes comparable to the 2 smaller urban centres included in this study.
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